Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, Jun 2026 and Jul 2026.
- Largest single sale: $6.1M (278,698 shares) of Adaptive Biotechnologies Corp on Jul 21, 2026. Filing
- Last sale before this period: May 1, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief Scientific Officer | Jun 26, 2019 | Jul 23, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 21, 2026, Adaptive Biotechnologies Corp: sold 492,400 shares for $10.8M, under a disclosed plan; 284,800 shares acquired by exercising options. 1 filing: 1
- Jul 2, 2026, Adaptive Biotechnologies Corp: sold 386,240 shares for $8.5M, under a disclosed plan. 1 filing: 1
- Jun 16, 2026, Adaptive Biotechnologies Corp: sold 6,160 shares for $111K, under a disclosed plan. 1 filing: 1
- Jun 15, 2026, Adaptive Biotechnologies Corp: sold 100,000 shares for $1.7M, under a disclosed plan. 1 filing: 1
- Apr 8, 2026, Adaptive Biotechnologies Corp: sold 10,000 shares for $149K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.